Trophoblast cell surface antigen 2 (Trop-2) is a transmembrane glycoprotein overexpressed in various epithelial malignancies, including breast cancer (10), lung cancer (11), and urothelial carcinoma (12). Here, TACSTD2 is linked to breast cancer.